Remi Meds is the only brand in its five-brand template family that prints how much liquid the figure buys — and it packs a volume, a dosing frequency, a month and a dose hedge into a single eleven-word price label.
What Remi Meds charges
NAD+: $349/mo — printed as "NAD+ 10 ml per week | $349/mo ~ starting dose". ⛔ The label carries a volume, a dosing frequency, a month AND a hedge about the dose in eleven words; the "~ starting dose" says the figure moves with titration and the page does not say by how much
Sermorelin: $249/mo — printed as "SERMORELIN 3 ml per week | $249/mo ~ starting dose". The same page prints "SERMORELIN 9 ml per week | $349/mo" as a separate line, so the volume, not the compound, is what moves the figure
Remi Meds is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
A volume, a frequency, a month and a hedge
The price labels here read: compound, a volume per week, a vertical bar, a figure with a month attached, a tilde, and the words starting dose. Every element does work and no element is explained.
The volume and frequency together are genuinely useful and genuinely rare. Three brands running this same template print a bare number with no unit of any kind; this one tells a reader how much liquid a week the money buys.
The hedge undoes some of that. Starting dose means the figure is a floor, and the page does not say what a higher dose costs. The growth-hormone product is the exception: two volumes appear as two lines at two figures, so the ladder is visible for that one product.
This site records the lower growth-hormone figure and names the higher volume in the qualifier, and records the coenzyme figure with its volume and frequency in the dose field.
Volume, not compound, is what moves the price
Reading the two growth-hormone lines together makes the pricing model explicit: three millilitres a week and nine millilitres a week are the same compound at different figures. It is a volume tariff.
That reframes the coenzyme's figure too. The number is attached to ten millilitres a week, and a reader taking a different volume is not being quoted at all.
This is the closest anything in this family comes to explaining its own pricing, and it comes from putting two lines next to each other rather than from a sentence the seller wrote.
Neither product page prints a concentration, so the volumes cannot be converted into a dose.
Both product paths redirect
The paths this session requested for both products returned a redirect to a services subdirectory. The pages served are real; the addresses requested are not the ones the seller uses.
That matters for citation rather than for shopping. A review citing the requested path would be citing a URL this seller does not serve, and a reader following it would land somewhere the seller redirected them rather than somewhere the seller published.
The roster cites the effective URLs on both price rows.
The nonsense-path control on this host returned a clean not-found status, so the redirect is a real rewrite rather than a host answering for every address.
The family, and what is missing
This brand's figures match a sibling's on several SKUs to the dollar, and a third brand matches on some of them. Five brands in this family publish three distinct price structures between them.
The terms carry the same arbitration clause as the siblings, naming an arbitration organisation and the law of a named state, and that name is the only corporate name on the page. No operating company is recorded here as a result.
The product pages state that the dose is determined by the licensed provider based on medical judgment, which is the family's shared clinical sentence.
No dispensing pharmacy is named, no certificate of analysis appears anywhere on the pages read, and no state coverage list is published. Screened by brand against the regulator's warning-letter index, this seller returns nothing.
Who it's for
Readers who want to know how much liquid a figure buys, which almost nothing else on this roster prints.
Buyers comparing two volumes of the same compound at two published figures.
Anyone who wants a month attached to a figure in this template family, where three brands attach nothing.
Shoppers who want a brand in this family with no enforcement letter against it.
Who should look elsewhere
Anyone titrating upward, since the figure is a starting dose and the ceiling is not published.
Readers who need a concentration to convert a volume into a dose.
Buyers who want an operating company published anywhere.
Shoppers who want a certificate of analysis, a named pharmacy, or a state coverage list.
Strengths
The only brand in its template family that prints a volume and a dosing frequency beside the figure
Publishes two volumes of the growth-hormone peptide at two figures rather than one "starting at"
Attaches a month to both peptide figures where three siblings attach nothing
Says the dose is determined by the licensed provider based on medical judgment
Trade-offs
The "~ starting dose" hedge means the printed figure is a floor and the page never says what the ceiling is
Its terms name only the arbitration provider, never an operating company
Both requested product paths redirect, so a cited product URL must be the effective one
No pharmacy named, no certificate of analysis, no state coverage list
How we verified this
Loaded both product paths and the terms with a full browser user-agent, printing the effective URL beside the requested one on each and recording that both product paths redirected.
Cited the effective URLs on both price rows rather than the requested ones.
Ran a nonsense-path control on the host in the same run, which returned a not-found status.
Joined the page's text nodes before matching any figure.
Read each price label element by element — compound, volume, frequency, figure, period, hedge — and recorded the volume and frequency in the dose field rather than discarding them.
Read the two growth-hormone lines together, which is what established that volume rather than compound is what moves the figure.
Compared this brand's SKU figures against the four sibling brands running the same template and counted the distinct price structures across the family.
Screened the brand name against the regulator's warning-letter index, with a nonsense query as a control in the same run.
A provider to compare Remi Meds against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
A stated volume per week at a stated monthly figure, described as a starting dose. The ceiling for a higher dose is not published except on the growth-hormone product, where two volumes appear at two figures.
Is the concentration published?
No. The volumes cannot be converted into a dose from anything on the pages read.
Do the product URLs work?
The paths requested here redirected to a services subdirectory. The pages exist; the addresses are different from the obvious ones, so cite the effective URL.
Who operates this brand?
Not established. The only corporate name on its terms belongs to an arbitration provider named in a clause shared with sibling brands.
Are its prices independent of the other brands here?
Not entirely. Several SKUs match a sibling brand's figures to the dollar, so those are one observation rather than two.
Remi Meds is not a paid partner; this link may earn a commission if that changes. Full disclosure.